Stages of Alzheimer’s Disease

A resident of Atlanta, Georgia, Eugene E Houchins III is the president and founder of the American Life Corp Fund. He enjoys college football, high school sports, and coaching little league in his free time. Eugene Houchins III is also in Alzheimer’s disease research.

Alzheimer’s disease is the most common type of dementia; it causes memory loss, confusion, changes in personality, and gradual loss of independence. It tends to develop slowly and worsen over the years, and in the final stage, people with Alzheimer’s disease may be unable to communicate with people or know what is going on around them.

Firstly, Alzheimer’s disease begins long before any symptoms become apparent, and this is called the preclinical stage. New imaging techniques can identify deposits of a protein called amyloid-beta, a hallmark of Alzheimer’s disease. Genetic tests can also tell you if you have a higher risk of developing Alzheimer’s. The capacity to detect these early deposits could be particularly useful in clinical trials and the future if new Alzheimer’s disease treatments are developed.

The second stage is the mild cognitive impairment stage, where mild changes in memory and thinking ability occur. However, it is important to note that not everyone with mild cognitive impairment has Alzheimer’s disease. This may be the slight amnesia that many people experience as they get older, but it may also cause concentration issues.

Subsequently, People with Alzheimer’s disease at the mild dementia stage become more confused and forgetful, requiring more assistance with everyday activities and self-care.

Lastly, the mental function continues to deteriorate in the late stages of Alzheimer’s disease, known as serious dementia, and the disease has a significant influence on movement and physical ability. Patients may generally lose bowel and bladder control, need help with all activities, and lose the ability to communicate effectively.

An Overview of Telemedicine

Telemedicine is a medical practice healthcare professionals use to diagnose and treat patients remotely. Specifically, they use telecommunications technologies to attend to patients at a distance. Doctors and other healthcare personnel use telemedicine to offer various services, including primary care consultation, physical therapy, psychotherapy, and emergency services.

Additionally, doctors use this practice to assess patients whether or not they need in-person treatment. Other times, they employ it to address minor infections and injuries and offer certain therapy types such as speech therapy. They also write and renew prescriptions remotely. A doctor recommends telemedicine when a patient can’t physically access a health center or must practice physical distancing.

Today, telemedicine involves using high-quality video tools. Telemedicine surfaced in the 1950s after university health centers and a handful of hospital systems introduced an image and information sharing platform using the telephone. During this time, a doctor attending to a patient would connect remotely with a distant specialist to access specialized care. This method helped populations residing in rural areas and other hard-to-reach places.

Over time, advancements in technology introduced better systems of connecting healthcare professionals with patients. Specifically, the internet’s proliferation and advances in technologies, including smartphones and other devices, have transformed telemedicine.

In the United States, telemedicine is fast growing into a healthcare delivery tool. More than half of all hospitals in the country use some telemedicine form. As of 2022, patients can access about 3,500 service locations distributed over 200 telemedicine networks. The practice is so beneficial that, in 2011, it helped reach over 300,000 veterans.

Telemedicine differs from telehealth. While telemedicine uses telecommunication technology to deliver care over a distance, telehealth is a broad term that entails telecommunications and electronic technologies that healthcare providers use to provide care remotely. Telemedicine specifically refers to offering clinical services at a distance. In contrast, telehealth can include non-clinical services. These include administrative meetings, training, and medical education.

A paramount concern for patients is how safe the practice is. This mainly involves the use of video tools. Experts say it is just as safe as in-person care for appropriate cases and under the right conditions. Not all cases call for video consultation. Therefore, the healthcare professional must rule out all other possibilities and consider it the only viable option.

Again, patients worry about their privacy and security, considering telemedicine transmits their data. Telemedicine must conform to the Health Insurance Portability and Accountability Act (HIPAA) regulations to address this. Consumer video platforms, including Facetime and Skype, don’t count since they don’t meet such rules. Instead, providers use technologies that decrypt and protect patient data.

Telemedicine benefits both the patient and the doctor. For patients, it lowers costs that would otherwise go to commuting and childcare when one visits a health center physically. It also enhances care provision to particular categories of people, including people with disabilities, the elderly, those geographically isolated, and those who’re incarcerated.

Additionally, telemedicine helps extend preventive care, especially to those with geographic and financial barriers limiting them from accessing physical health centers. Besides, this practice slows the spread of infectious diseases, including COVID-19.

For healthcare providers, there are few overhead costs. Thus, they pay less for front desk support or rent a few examination rooms. Also, for established health centers, telemedicine offers an additional income stream. Besides, it helps protect them from infectious diseases.

Two Categories of Complementary and Alternative Medicine

An established entrepreneur and financial professional in Georgia, Eugene E. Houchins III serves as the president of American Life Fund Corp. Eugene Houchins III oversees viatical settlements, which provide life-insurance policyholders with cash payouts that they can put toward living expenses, medical costs, or alternative or complementary treatments.

Complementary and alternative medicine (CAM) refers to products and practices that either supplement or offer an alternative to standard treatments and medical care. They fall into five categories, two of which comprise biofield therapy and mind-body therapies. Mind-body therapies help alleviate stress and relax the body. Yoga, meditation, hypnosis, and biofeedback represent a few such methods. These therapies incorporate breathing techniques, mental focus, and body movements to support relaxation. For example, yoga emphasizes attention to breathing while engaging in physical poses and stretches.

Biofield therapy, or energy medicine, attempts to foster wellness and healing by activating energy fields presumed by some practitioners to surround the body. When performing biofield therapy, the therapist places their hands in or through the patient’s biofield to stimulate a healing response. Types of energy medicine include Reiki and therapeutic touch. Reiki sometimes involve direct contact with the patient’s body, while therapeutic touch is restricted to movement over their energy fields.

Mild Behavioral Impairment an Early Indicator of Alzheimer’s

Based in Atlanta, Eugene E. Houchins III is the founder and president of the American Life Fund Corp, a company that offers pathways to funds for people with life-threatening conditions. Eugene E. Houchins III is particularly interested in cancer research and Alzheimer’s disease research.

According to recent research conducted at the McGill University Research Centre for Studies in Aging, a correlation exists between mild behavioral impairment (MBI) and Alzheimer’s disease. The noncognitive symptoms of MBI typically occur among individuals who are still cognitively healthy.

The study found that MBI is strongly associated with amyloid plaques in the brain, which is an initial pathological change associated with the early stages of Alzheimer’s. These specific proteins are associated with abnormal human behavior such as MBI, which can subsequently manifest as memory loss.

By using an MBI checklist, physicians may be able to identify people who are at a higher risk of dementia even before symptoms begin to manifest. The result will be treatment at earlier stages of Alzheimer’s progression, which may have a greater chance of slowing or reversing the disease.